Vaccines

How Coronavirus Variants May Drive Reinfection and Shape Vaccination Efforts

Q&A with Aubree Gordon

Vaccine rollout in the United States has been undeniably slow. And while we wait, worrisome new coronavirus variants are emerging, heightening the urgency to control the pandemic. Some variants, including ones first identified in Brazil, South Africa and the United Kingdom, have mutations that help the coronavirus evade parts of the immune system, raising the specter that some people might face a second round of COVID-19.

Does Getting the Covid-19 Vaccine Stop You Spreading It? Scientists Don't Know Yet.

Arnold Monto featured in the Wall Street Journal

The Covid-19 vaccines authorized in the U.S. are approximately 95% effective at preventing people from getting sick with symptoms, according to Pfizer and Moderna, the companies that produce them. But scientists are still studying whether vaccination prevents transmission to others.

Program To Vaccinate 450 Million Europeans Gets Underway

Scott Greer featured on CBS This Morning

Health Management and Policy professor Scott Greer discusses methods for people to receive the COVID-19 vaccine.

U-M Expert, Leukemia Survivor Discusses Why He Plans to Get the COVID-19 Vaccine

Q&A with Ryan Malosh

Malosh says getting as many people vaccinated as possible will be key to stopping the spread of the COVID-19 pandemic. Until then, he says, public health measures such as social distancing, wearing a mask, and hand washing continue to be people's best protection.

Pfizer Shot Gets FDA Advisers' Nod as Agency Decision Nears

Arnold Monto featured in Bloomberg

The first Covid-19 vaccine expected to be deployed in the U.S. won the backing of a panel of government advisers, a step that will likely help clear the way for emergency authorization by the Food and Drug Administration.

Three Things to Know about the COVID-19 Vaccines

Here are three key takeaways from the December 2 discussion on vaccine development with infectious disease expert and University of Michigan School of Public Health professor Arnold Monto.